Key Market Indicators
Medical product expenditure in the UK is expected to reach €22.7 billion by 2026, up 2.2% per year on average from 2021's €20.1 billion. Since 2000, demand for medical products in the UK has been rising by an average of 5% per year. In 2021, France was the second-biggest market for medical products in Europe, with €20.1 billion in expenditure. The UK was third, followed by Italy.
The United Kingdom Medical Device Market Data and Forecasts
What is the size of the British Medical Device Market in 2022?
More in Medical Device Industry in major countriesImprove your Knowledge with the latest Indicators and Trends
-
Eyewear Evolution: Contact Lenses and Spectacles Redefining Vision Correction Trends
The eyewear industry has experienced remarkable transformation over the years. Notably, contact lenses and spectacles dominate the vision correction segment. With technological advancements and increasing consumer demand for more convenient, stylish, and effective eyewear, both manufacturers and consumers are exploring new frontiers in vision correction options.
Discover more insights -
Optics Industry: Exploring the Diverse Dynamics of the Global Spectacles Market
The growth trajectory of the global spectacles market is heavily influenced by the rising prevalence of ocular disorders, an aging population, and an unprecedented increase in screen time. Other key factors propelling this sector are the growing awareness about eye health and the focus on style and aesthetics as spectacles...
Discover more insights -
Medical Equipment: Emerging Dynamics of Special Purpose Needles Market
The demand for special purpose needles emanates from specific medical procedures requiring precision, such as biopsy, aspiration, or injection into delicate tissues. This demand can be attributed to a growing prevalence of chronic illnesses, and an increasing number of diagnostic and therapeutic procedures stemming from it. Amid surging healthcare expenditures...
Discover more insights -
Deciphering Diabetes: Evaluating Emerging Treatments through Pipeline Reviews
The therapeutic landscape for diabetes is witnessing a significant transformation as an array of innovative treatments steadily progresses through clinical pipeline reviews. Unprecedented pharmacological advancements, characterized by both novel mechanisms of action and improved administration protocols, herald an imminent paradigm shift in managing both type 1 and type 2 diabetes.
Discover more insights -
Orthopedics Industry: Navigating Challenges and Harnessing Technological Advancement for Optimum Performance
The global orthopedics industry, like many industries in the healthcare sector, faces its own unique set of obstacles. A critical challenge is the increasing regulatory scrutiny which is causing significant delays in the introduction of legislative procedures and prototype releases. Another major challenge is the recruitment and retention of skilled...
Discover more insights